Synthetic low-molecular weight or endogenous MMP inhibitors or an anti-catalytic MMP-9 antibody blocked increased invasive activity after EGF-mediated induction, indicating EGFR activation results in enhanced MMP-9 expression and may facilitate the removal of extracellular matrix barriers to tumor invasion. This evidence concerns the gene MMP9 and neoplasm.